Plunkett Research Online: Dicerna Pharmaceuticals Inc

DICERNA PHARMACEUTICALS INC (DRNA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

A biopharmaceutical company.....

Dicerna Pharmaceuticals Inc
Ticker: DRNA
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 617 621-8097
Address: 33 Hayden Avenue
Lexington, MA 02421 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs)
Contacts Description

Douglas Fambrough CEO/Director/President
John Green CFO/Chief Accounting Officer
See More
A biopharmaceutical company.....See More See More

Auditor: Deloitte & Touche LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: